Inventaire - your friends and communities are your best library

Epigenetic Targeting of Transforming Growth Factor β Receptor II and Implications for Cancer Therapy

এতে প্রকাশিত: Molecular and cellular pharmacology

তারিখে প্রকাশিত: 2009-01-01

Cites articles 105

তারিখ

শিরোনাম

লেখকগণ

2008-11-13

Timing is everything: order of administration of 5-aza 2' deoxycytidine, trichostatin A and tamoxifen changes estrogen receptor mRNA expression and cell sensitivity

Judith Clancy Keen
2008-10-22

G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription
2008-09-12

Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells

Morten Grauslund, Thomas Litman
2008-09-01

Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas

Silvia Darb-Esfahani, Aurelia Noske, Wilko Weichert, Manfred Dietel
2008-05-08

CpG island methylator phenotype (CIMP) in cancer: causes and implications
2008-05-06

Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy
2008-05-01

Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease
2008-04-01

Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers

Toshikazu Ushijima
2008-03-15

Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo

Ann-Christin Buckendahl, Aurelia Noske, Wilko Weichert, Silvia Niesporek, Manfred Dietel
2008-03-10

Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter

Wen Zhou, Wei-Guo Zhu
2008-01-01

HDACs and HDAC inhibitors in colon cancer
2008-01-22

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

Carsten Denkert, Klaus Jung
2008-01-16

KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor

Rolf Renne
2008-01-01

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
2008-08-01

Epigenetics? Mediator does that too!
2008-05-01

Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells
2007-12-01

Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis

Clare Stirzaker, Bryce Vissel, Timothy Ravasi, Christine A Wells, ডেভিড এ হিউম, Roger Reddel, স্টুয়ার্ট জে ক্লার্ক, সুসান ক্লার্ক
2007-08-24

Expression of HDAC1 and CBP/p300 in human colorectal carcinomas
2007-08-13

Histone deacetylases and cancer
2007-07-25

Functional dynamics of H3K9 methylation during meiotic prophase progression
2007-01-01

Histone deacetylase inhibitors: biology and mechanism of action
2007-08-01

Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications

Elisabetta Fratta, Sandra Coral, Alessia Covre, Hugues Nicolay, Luana Calabro', Michele Maio
2007-08-01

Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells
2007-04-07

HDAC inhibitors: clinical update and mechanism-based potential.
2007-01-31

TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.

Massimo Loda, Charles S. Fuchs, Gregory J Kirkner, Shuji Ogino
2007-09-01

Progressive up-regulation of genes encoding DNA methyltransferases in the colorectal adenoma-carcinoma sequence

Sabine Zöchbauer-Müller, Robert M. Mader
2006-11-29

Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells
2006-09-01

Transforming growth factor-beta in cancer and metastasis
2006-07-08

Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer

Katerina Pardali
2006-06-26

5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation
2006-04-01

Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state

Stephen B. Baylin, Thomas Jenuwein
2006-01-01

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines

Rafal Dziadziuszko, Fred R Hirsch

নিবন্ধ - wd:Q33802356

জায়ে আপনাকে স্বাগত

the library of your friends and communities

আরো জানুন